Clinical Trial Update: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating belantamab mafodotin in combination with carfilzomib, pomalidomide, and dexamethasone for relapsed multiple myeloma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Blenrep (belantamab mafodotin) (belantamab mafodotin)
• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib) (carfilzomib)
• Pomalyst (pomalidomide) (pomalidomide)

Snippet

Sponsor: University of Chicago | Conditions: Multiple Myeloma, Relapse Multiple Myeloma | Phase 2 | Status: RECRUITING